Cytokine Registry Database of Stroke Patients (CRISP)

Journal of Health Disparities Research and Practice
Volume 12
Issue 5 Mountain West CTR-IN Special Issue

Article 11

© Center for Health Disparities Research, School of Public Health, University of Nevada, Las Vegas

2018

Cytokine Registry Database of Stroke Patients (CRISP)
Atif Zafar , University of New Mexico
Fares Qeadan , University of New Mexico
Asad Ikram , University of New Mexico
See next page for additional authors

Follow this and additional works at: https://digitalscholarship.unlv.edu/jhdrp
Part of the Medicine and Health Sciences Commons

Recommended Citation
Zafar, Atif; Qeadan, Fares; Ikram, Asad; Farooqui, Mudassir; Suriya, Sajid; and Paul, Surojit (2018) "Cytokine
Registry Database of Stroke Patients (CRISP)," Journal of Health Disparities Research and Practice: Vol.
12 : Iss. 5 , Article 11.
Available at: https://digitalscholarship.unlv.edu/jhdrp/vol12/iss5/11

This Article is protected by copyright and/or related rights. It has been brought to you by Digital Scholarship@UNLV
with permission from the rights-holder(s). You are free to use this Article in any way that is permitted by the
copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from
the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/
or on the work itself.
This Article has been accepted for inclusion in Journal of Health Disparities Research and Practice by an
authorized administrator of Digital Scholarship@UNLV. For more information, please contact
digitalscholarship@unlv.edu.

Cytokine Registry Database of Stroke Patients (CRISP)
Abstract
Purpose/Background: The aim of the study is to identify molecular biomarkers involve in patients who
present with stroke and to determine their clinical usefulness as potential biomarkers in stroke patients
as compared to patients without stroke.
Materials & Methods: All patients presenting with ischemic stroke and hemorrhagic stroke at University of
New Mexico Hospital (UNMH) will be screened for potential participation in this study based on following
inclusion and exclusion criteria:
Inclusion criteria: male/female of ages ≥ 18 years, patients whose standard stroke admission order sets
are obtained for clinical care.
Exclusion criteria: Patients <18 >year, with the history of prior stroke or any neurodegenerative or
neuroinflammatory disease except multiple sclerosis (MS), pregnant women and prisoners.
Cytokines will be measured in serum at two different time points: on admission and after 24 hours of
admission. The biomarkers which will measured in serum will include interleukin (IL)-1, 4, 6, 10, 17, 23, 33,
36, 37, PDGF, VEGFM, TNF-a, ANNULIN, MMP-9, 12, NFk-B, MPO and glial factors; GMF, SI000-B and
GM-6001. These biomarkers will be evaluated using enzyme linked immunosorbent assay (ELISA).
Twenty-five percent of the total stroke patient serum samples will be matched by controls without
ischemic or hemorrhagic stroke.
The study was approved by UNM institutional review board (IRB). All sample and data collection is being
done after patient or legally authorized individual sign the informed consent form. All the data is being
collected on secured RedCAP database.
Results: A total of 105 patients will be enrolled during the study period. Two sets of samples; one at
baseline and the other after 24 hours of admission, will collected from each enrolled patient. At present,
two patients are enrolled and their samples have been collected and stored per study protocol. The study
is currently under recruitment phase and it is anticipated that the enrollment will be completed within next
2 months. Biomarker analysis will be done sequentially as patients will be enrolled per study protocol.
Discussion/Conclusion: The CRISP study will give us understanding about the role of various cytokines
and/or other biomarkers in the pathogenesis of formation of stroke. These biomarkers can potentially
serve as identifiers in the clinical surveillance for acute stroke patients. The data from this study can be
beneficial in the acute management of stroke patients.
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ABSTRACT
Purpose/Background: The aim of the study is to identify molecular biomarkers involve in
patients who present with stroke and to determine their clinical usefulness as potential biomarkers
in stroke patients as compared to patients without stroke.
Materials & Methods: All patients presenting with ischemic stroke and hemorrhagic stroke
at University of New Mexico Hospital (UNMH) will be screened for potential participation in this
study based on following inclusion and exclusion criteria:
Inclusion criteria: male/female of ages ≥ 18 years, patients whose standard stroke
admission order sets are obtained for clinical care.
Exclusion criteria: Patients <18 year, with the history of prior stroke or any
neurodegenerative or neuroinflammatory disease except multiple sclerosis (MS), pregnant women
and prisoners.
Cytokines will be measured in serum at two different time points: on admission and after
24 hours of admission. The biomarkers which will measured in serum will include interleukin (IL)1, 4, 6, 10, 17, 23, 33, 36, 37, PDGF, VEGFM, TNF-a, ANNULIN, MMP-9, 12, NFk-B, MPO and
glial factors; GMF, SI000-B and GM-6001. These biomarkers will be evaluated using enzyme
linked immunosorbent assay (ELISA). Twenty-five percent of the total stroke patient serum
samples will be matched by controls without ischemic or hemorrhagic stroke.
The study was approved by UNM institutional review board (IRB). All sample and data
collection is being done after patient or legally authorized individual sign the informed consent
form. All the data is being collected on secured RedCAP database.
Results: A total of 105 patients will be enrolled during the study period. Two sets of
samples; one at baseline and the other after 24 hours of admission, will collected from each
enrolled patient. At present, two patients are enrolled and their samples have been collected and
stored per study protocol. The study is currently under recruitment phase and it is anticipated that
the enrollment will be completed within next 2 months. Biomarker analysis will be done
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sequentially as patients will be enrolled per study protocol.
Discussion/Conclusion: The CRISP study will give us understanding about the role of
various cytokines and/or other biomarkers in the pathogenesis of formation of stroke. These
biomarkers can potentially serve as identifiers in the clinical surveillance for acute stroke patients.
The data from this study can be beneficial in the acute management of stroke patients.
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